Global RNA Analysis/ Transcriptomics market overview 2024, Forecast To 2033

The RNA analysis/transcriptomics market has demonstrated substantial growth, increasing from $6.89 billion in 2023 to $7.91 billion in 2024, showcasing a compound annual growth rate (CAGR) of 14.9%. This growth in the historic period is attributed to factors such as cancer research and precision medicine, drug discovery and development, infectious disease diagnostics, personalized medicine, academic and government funding, and growing applications in agriculture. In the forecast period, the RNA analysis/transcriptomics market is projected to continue its rapid growth, reaching $14.2 billion in 2028, with a CAGR of 15.7%. Key drivers for this growth include single-cell RNA sequencing applications, integration of RNA analysis in clinical diagnostics, RNA-based therapies and vaccines, bioinformatics, and data analysis tools, as well as biomarker discovery and validation. Notable trends in the forecast period include spatial transcriptomics and in situ RNA analysis, long-read RNA sequencing technologies, RNA editing and modification analysis, integration of AI in RNA data analysis, RNA therapeutics for rare diseases, and RNA-based liquid biopsy for cancer detection.